GSK-3 as a therapeutic target of lithium

被引：0
|
作者：
Klein, P. S. [1 ]
机构：
[1] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2006年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [21] Therapeutic utility of GSK-3 inhibitors for the treatment of cancer
    Chedid, Marcio
    Gutowski, Magda
    Evans, Robert J.
    Brail, Leslie
    Horton, Noel D.
    Jackson, Kimberley
    Engler, Thomas A.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [22] GSK-3 inhibitors: Recent developments and therapeutic potential
    Kaku, Shinsuke
    Chaki, Shigeyuki
    Muramatsu, Makoto
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2008, 3 (03) : 195 - 205
  • [23] Lysophospholipid signalling as a therapeutic target for human skin wound healing: role of GSK-3β/β-catenin signalling
    Johnson, D. L.
    Jahoda, C. A.
    Reynolds, N. J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S101 - S101
  • [24] GSK-3β as a target for protection against transient cerebral ischemia
    Wang, Wei
    Li, Mingchang
    Wang, Yuefei
    Wang, Zhongyu
    Zhang, Wei
    Guan, Fangxia
    Chen, Qianxue
    Wang, Jian
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2017, 14 (04): : 333 - 339
  • [25] Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer
    Darrington, R. Siobhan
    Campa, Victor M.
    Walker, Marjorie M.
    Bengoa-Vergniory, Nora
    Gorrono-Etxebarria, Irantzu
    Uysal-Onganer, Pinar
    Kawano, Yoshiaki
    Waxman, Jonathan
    Kypta, Robert M.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (06) : E872 - E883
  • [26] Pathobiology and Therapeutic Relevance of GSK-3 in Chronic Hematological Malignancies
    Martelli, Alberto M.
    Paganelli, Francesca
    Evangelisti, Camilla
    Chiarini, Francesca
    McCubrey, James A.
    CELLS, 2022, 11 (11)
  • [27] Identification of GSK-3 as a Potential Therapeutic Entry Point for Epilepsy
    Aourz, Najat
    Serruys, Ann-Sophie K.
    Chabwine, Joelle N.
    Balegamire, Pascal Byenda
    Afrikanova, Tatiana
    Edrada-Ebel, RuAngelie
    Grey, Alexander I.
    Kamuhabwa, Appolinary R.
    Walrave, Laura
    Esguerra, Camila V.
    van Leuven, Fred
    de Witte, Peter A. M.
    Smolders, Ilse
    Crawford, Alexander D.
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (04): : 1992 - 2003
  • [28] GSK-3 IS A POTENTIAL THERAPEUTIC TARGET FOR THE TREATMENT OF RENAL CELL CARCINOMA (RCC): PRECLINICAL IN VITRO AND IN VIVO INVESTIGATION
    Kawazoe, Hisashi
    Bilim, Vladimir
    Yuuki, Kaori
    Muto, Akinori
    Ougolkov, Andrei V.
    Billadeau, Daniel D.
    Oya, Mototsugu
    Motoyama, Teiichi
    Tomita, Yoshihiko
    JOURNAL OF UROLOGY, 2009, 181 (04): : 152 - 153
  • [29] Therapeutic Concentration of Lithium Stimulates Complement C3 Production in Dendritic Cells and Microglia via GSK-3 Inhibition
    Yu, Zhiqian
    Ono, Chiaki
    Aiba, Setsuya
    Kikuchi, Yoshie
    Sora, Ichiro
    Matsuoka, Hiroo
    Tomita, Hiroaki
    GLIA, 2015, 63 (02) : 257 - 270
  • [30] Inhibition of GSK-3: A novel therapeutic approach for breast cancer treatment
    Ugolkov, Andrey
    Gaisina, Irina
    Malin, Dmitry
    Kulesza, Peter
    Kozikowski, Alan
    Cryns, Vincent
    Mazar, Andrew
    MOLECULAR CANCER RESEARCH, 2013, 11
12345